Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease

NCT00004408 is registered in ClinicalTrials.gov with Mast Therapeutics, Inc. as lead sponsor.

NCT NCT00004408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease
Lead sponsor
Mast Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
November 30, 1997
Completion date
November 30, 1999
Enrollment
300
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell anemia